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The Transcription Factor E4BP4 Is Not Required for
Extramedullary Pathways of NK Cell Development
Stefania Crotta,*,1 Annita Gkioka,*,1 Victoria Male,† Joa˜o H. Duarte,* Sophia Davidson,*
Ilaria Nisoli,† Hugh J. M. Brady,† and Andreas Wack*
NK cells contribute to antitumor and antiviral immunosurveillance. Their development in the bone marrow (BM) requires the
transcription factor E4BP4/NFIL3, but requirements in other organs are less well defined. In this study, we show that CD32
NK1.1+NKp46+CD122+ NK cells of immature phenotype and expressing low eomesodermin levels are found in thymus, spleen,
and liver of E4BP4-deficient mice, whereas numbers of mature, eomesoderminhigh conventional NK cells are drastically reduced.
E4BP4-deficient CD44+CD252 double-negative 1 thymocytes efficiently develop in vitro into NK cells with kinetics, phenotype,
and functionality similar to wild-type controls, whereas no NK cells develop from E4BP4-deficient BM precursors. In E4BP4/Rag-1
double-deficient (DKO) mice, NK cells resembling those in Rag-1–deficient controls are found in similar numbers in the thymus and
liver. However, NK precursors are reduced in DKO BM, and no NK cells develop from DKO BM progenitors in vitro. DKO
thymocyte precursors readily develop into NK cells, but DKO BM transfers into nude recipients and NK cells in E4BP4/Rag-1/IL-7
triple-KO mice indicated thymus-independent NK cell development. In the presence of T cells or E4BP4-sufficient NK cells, DKO
NK cells have a selective disadvantage, and thymic and hepatic DKO NK cells show reduced survival when adoptively transferred
into lymphopenic hosts. This correlates with higher apoptosis rates and lower responsiveness to IL-15 in vitro. In conclusion, we
demonstrate E4BP4-independent development of NK cells of immature phenotype, reduced fitness, short t1/2, and potential extra-
medullary origin. Our data identify E4BP4-independent NK cell developmental pathways and a role for E4BP4 in NK cell
homeostasis. The Journal of Immunology, 2014, 192: 2677–2688.
N
atural killer cells are central to innate immune defenses
and patrol the organism to recognize and eliminate virus-
infected, stressed, or transformed cells (1). NK cells are
activated by cell-contact–dependent or cytokine-mediated stimuli
(2–4), and their response includes cytotoxic function and pro-
duction of IFN-g and proinflammatory cytokines that impact on
subsequent adaptive immune responses (5).
The bone marrow (BM) is the best-characterized site of con-
ventional NK (cNK) cell development, where common lymphoid
progenitors (CLPs) (6) give rise to NK cells in an IL-15–depen-
dent process (7–10). The developing cells pass through a NK-
committed precursor stage (11) with the phenotype Lin2CD27+
2B4+CD127+Flt32. This population can be further subdivided into
pre–NK cell precursors (NKP), which do not express the IL-15R
b-chain (CD122), and refined NKP, which are CD122+ (12, 13).
The later steps of NK cell maturation follow a well-defined se-
quence of phenotypic changes (14–16).
Apart from the intramedullary development of cNK cells, there
are also distinct extramedullary NK cell populations resident in
peripheral sites, such as liver, gut, or peritoneum, which often
express distinct combinations of surface markers (15, 17, 18). For
instance, the liver contains a population of NK cells with an im-
mature DX52TRAILhigh phenotype. These stable differences in
marker expression, together with the identification of peripheral
precursors with NK cell potential, support the possibility of extra-
medullary NK cell generation (19). However, the control of NK cell
differentiation in extramedullary sites is still poorly understood.
A unique population of NK cells is present in the thymus (20).
Unlike BM NK cells, they express the IL-7R (CD127) and rely
upon IL-7 for their development. Thymic NK cells express the
maturation marker CD11b and some Ly49 receptors at lower levels
than that of splenic NK cells, suggesting that they are compara-
tively immature (21). Although the pathway by which thymic NK
cells develop has not yet been described in detail, they may orig-
inate from double-negative (DN)1 and DN2 thymocytes, which
retain both NK and T cell potential (22–24). In support of this,
sorted DN1 thymocytes differentiate in vitro and in vivo into cells
that more closely resemble thymic, not splenic, NK cells (25).
Much work is now directed toward identifying the transcription
factors required for NK cell development (26). Id2 (27, 28), Ets1
(29), T-bet, and eomesodermin (Eomes) (30) were all shown to be
essential for the production of normal numbers of mature NK cells
in the BM. In particular, T-bet and Eomes show high sequence
similarity and have overlapping functions in NK cells (30).
Less is known about the transcriptional requirements of extra-
medullary NK cells. In the liver, the DX52TRAIL+ subset of NK
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cells mentioned above can develop in the absence of Eomes (30).
The production of thymic NK cells is critically dependent upon
GATA-3 (20), whereas BM NK cells can develop in the absence of
this transcription factor, despite having defects in IFN-g produc-
tion and migration to the liver (31). Therefore, the transcription
factors required for intramedullary and extramedullary develop-
ment of NK cells differ (32).
The transcription factor E4BP4/NFIL3 is a basic leucine zipper
transcription factor that is implicated in a number of immune
processes (33). It is absolutely required for the development of
cNK cells in the BM, as E4bp4-deficient mice have strongly re-
duced numbers of mature NK cells in BM, spleen, liver, and
lymph nodes (34, 35). However, the effect of E4BP4 deficiency on
NK subsets in other organs has not yet been explored.
In this study, we tested the requirement for E4BP4 in NK cell
development at medullary and extramedullary sites and define
in vitro and in vivo conditions of E4BP4-independent NK cell
development. Our data suggest that NK cells can develop inde-
pendently of E4BP4, possibly through an extramedullary pathway,
resulting in peripheral NK cells with reduced fitness.
Materials and Methods
Mice
Wild-type (wt), IL-7–deficient, E4BP4-deficient (34), and Rag-1–deficient
(36) mice on the C57BL/6 background were bred and intercrossed at
Medical Research Council– National Institute for Medical Research under
specific pathogen-free conditions according to protocols approved by the
United Kingdom Home Office and the local ethics committee.
Influenza infection
Rag or double-deficient (DKO) mice were infected with 800 tissue culture-
infective doses50 of X31 (a H3N2 reassortant with the backbone of A/PR/8/
34) grown in Madin-Darby canine kidney cells. Single-cell suspensions were
prepared from day 3 and day 6 infected lungs, and NK cells were either
identified ex vivo by flow cytometry, or lung lymphocytes were stimulated for
4 h using phorbol dibutyrate/ionomycin in the presence of brefeldin A and
stained for IFN-g and NK cell markers.
Flow cytometry
Spleens and thymi were passed through 70-mm cell strainers and washed
with FACS buffer (10% BSA in PBS azide). RBCs were lysed using
ammonium chloride. Livers or lungs were first homogenized using gen-
tleMACS (Miltenyi Biotec), as per manufacturer’s instructions, and passed
through a 70-mm strainer. After centrifugation, liver cells were resus-
pended in 40% Percoll and overlaid on 60% Percoll (GE Healthcare).
Lymphocytes were then isolated at the interphase after centrifugation
(30 min at 900 3 g).
Cells were preincubated with anti-FcgRIII/II in FACS buffer prior to
a 30-min incubation with one or more of the following fluorochrome-
labeled Abs (Cambridge Bioscience, unless otherwise stated): anti-CD45,
anti-CD45.1, anti-CD45.2, anti-CD49b (DX5), anti-NKp46, anti-Ly49G2, anti-
CD122, anti-NKp46, anti-NK1.1, anti-Ly49D, anti-Ly49A/D, anti-Ly49C/I/F/H,
anti-CD11b, anti-CD127, anti-Eomes, anti–T-bet, anti-CD3, anti–IL-15Ra,
anti-CD4 (BD Biosciences), and anti-CD8 (BD Biosciences). NKP stains
were performedusingmAbs against 2B4 (R&DSystems) andCD27,CD127,
CD117, CD122, Flt3, and Sca-1 (all from eBioscience). Cells were then
stained with 7-aminoactinomycin D, TOPRO-3, or Aqua (Invitrogen) to
exclude dead cells. Data were acquired using a LSR II or Canto (BD Bio-
sciences) using DIVA software and analyzed using FlowJo software (Tree
Star). The lineage mixture for sorting lin2 cells contained the biotin- or PE-
conjugated Abs anti-B220, anti-CD3, anti-CD4, anti-CD8, anti-CD11b, anti-
CD11c, anti-CD19, anti–GR-1, anti-NK1.1, and anti–TER-119. Binding
of biotinylated Abs was visualized using allophycocyanin-Cy7–conju-
gated streptavidin.
Cell culture
For bulk culture of DN thymocytes or BM precursors, sorted thymic DN
(live lin2CD42CD82CD32NK1.12CD1222) cells or BM precursors (live
CD11b2CD11c2CD192Ter1192Ly6G2CD8a2CD3ε2CD45R2NK1.12)
were seeded at 3000 cells/well on g-irradiated GFP-transfected OP9 or
OP9-DL1 (24) stromal cells in IMDM containing 20% FBS (Stem Cell
Technologies), 50 mM 2-ME, L-glutamine, and pen/strep supplemented
with IL-7 (5 ng/ml), stem cell factor (SCF; 5 ng/ml), Flt3L (5 ng/ml), and
IL-15 (20 ng/ml) (25). Cells received fresh media every 4 d and were
cultured for 19 d in total. Alternatively, BM precursors were cultured first
with SCF (100 ng/ml), Flt3L (10 ng/ml), and IL-7 (10 ng/ml) for 5 d and
subsequently on OP9 cells with IL-15 (30 ng/ml) for 7 d, as described in
Gascoyne et al. (34).
Limiting dilution analysis
Sorted total DN thymocytes (live lin2CD1222NK1.12CD42CD82CD32)
or the subsets DN1 (CD44+CD252c-kit+), DN2 (CD44+CD25+) or DN3
(CD442CD25+), or double-positive (DP; live NK1.12CD4+CD8+) thy-
mocytes, were cultured, as described above, with input cell numbers per
well varying from 30 to 3000 cells. After 14 d of culture, cells from each
well were separately stained and analyzed by FACS. Wells containing .100
CD32NK1.1+NKp46+ NK cells were counted as positive. The fractions of
positive and negative wells were then used to calculate the NK precursor
frequency within each input population, as described by Hu and Smyth (37).
Cytokine-induced IFN-g production
In vitro generated NK cells rested for 36 h without OP-9 in IL-15 (10 ng/ml),
or freshly obtained splenic NK cells, were cultured in IL-12 (10 ng/ml) or
IL-18 (50 ng/ml) alone or in combination. After 1 h of culture, brefeldin A
(2.5 mg/ml) was added, and, after 16 h of culture, cells were fixed and
permeabilized (Cytofix/Cytoperm; BD Biosciences) and IFN-g was detec-
ted by intracellular staining.
In vitro NK cell function
For stimulation with plate-bound Abs, ELISA plates were coated with
purified Abs against NK1.1 (PK136, 10 mg/ml) and NKp46 (29A1.4, 5mg/
ml) overnight at 4˚C. Plates were then washed with PBS and seeded with
enriched NK cells from spleen. When appropriate, anti-CD107a Ab (BD
Biosciences) was added to the culture at the initiation of the incubation
period. Brefeldin A (10 mg/ml) and Golgi-Stop (0.7 ml/106 cells; BD Bio-
sciences) were added 2 h after the culture started. Cells were then assessed by
flow cytometry for cell surface markers and intracellular IFN-g.
For in vitro cytotoxicity assay, enriched NK cells were incubated with
YAC-1 target cells in triplicate. Supernatants were harvested after 5 h and
analyzed for specific lactate dehydrogenase release using the Cytotox96
nonradioactive cytotoxicity assay (Promega).
For the analysis of cell division, splenocytes were labeled for 8 min with
1 mM CFSE (Molecular Probe), washed with FBS-containing medium,
and cultured for 3 d in vitro in 24-well plates (1 3 106 cells/well) in the
presence or absence of murine rIL-15 (PeproTech; 50 ng/ml).
5-ethynyl-29-deoxyuridine in vivo proliferation assay
Mice received injections of 1 mg 5-ethynyl-29-deoxyuridine (EdU) once or
daily for 3 d and were analyzed 12 h after last injection. Single-cell suspen-
sions of thymus, spleen, liver, and BM were stained for surface expression of
NK1.1, DX5, CD11b, and CD122 and fixed in 4% formaldehyde (Sigma-
Aldrich); intranuclear labeling of EdU-containing DNA was performed
according to the manufacturer’s instructions (Invitrogen). The Live/Dead
Aqua Stain kit (Life Technologies) was used for dead cell exclusion.
BM chimeras
Rag-12/2 or E4BP4/Rag-12/2 (B6) BM cells were injected i.v. into sub-
lethally irradiated nude (BALB/c) or BALB/c wt control mice. Organs of
recipients were analyzed 8 wk or 8 mo after transplant, and donor NK cells
were identified by expression of H-2b MHC and of NK1.1.
For mixed BM chimeras, E4BP4/Rag-12/2 (CD45.2) BM cells (95%)
were injected i.v. into sublethally irradiated Rag12/2 mice, together with
either Rag22/2CD45.1+ or C57BL/6 CD45.1+ (5%) BM cells. Chimeric
mice were analyzed 8 wk posttransplantation.
Adoptive transfer studies
Nonirradiated Rag-22/2IL2rg2/2mice were injected i.v. with the following:
106 thymocytes from Rag-12/2 mice (7.6% CD32, NK1.1+, NKp46+
CD122+ NK cells) or E4BP4/Rag12/2 (4.9% CD32, NK1.1+, NKp46+
CD122+ NK cells); 106 purified hepatic lymphocytes from Rag-12/2 mice
(36.5% CD3-NK1.1+NKp46+CD122+ NK cells) or E4BP42/2Rag-12/2
(21% CD32NK1.1+NKp46+CD122+ NK cells). All mice were analyzed
3 wk posttransfer.
Transfer of CD4 T cells into Rag12/2 or E4BP4/Rag12/2 mice was
performed, as follows: 106 CD4 T cells were MACS purified according to
manufacturer’s instructions (Miltenyi Biotec) from CD45.1 B6 splenocytes
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and injected i.v. into CD45.1-negative recipients. Mice were analyzed 4 wk
after transfer for endogenous NK cell absolute numbers in thymus, spleen,
liver, and BM, as described above.
Results
E4BP4 deficiency affects NK cells in the spleen more than in
thymus and liver
It was previously reported that the transcription factor E4BP4 is
required for cNK cells in BM, spleen, liver, and lymph nodes;
however, development of NK cells of other origins or presence
of NK cells in other organs was not studied in detail (34, 35).
Therefore, we assessed NK cell numbers and phenotypes in thymi,
spleens, and livers of E4BP4-deficient mice. Total lymphocytes
were first gated on the CD32NK1.1+ population (Fig. 1, left
panels) and further separated from the overlapping (CD3intNK1.1+)
NKT cells and other innate lymphocyte cell subsets by gating on
the CD122+NKp46+ population (middle panels). In the absence of
E4BP4, frequencies and numbers of total NK cells (CD32NK1.1+
NKp46+CD122+) were significantly reduced in all organs. Splenic
NK cells that are generated mainly through medullary development
from BM precursors are most strongly reduced (34-fold), in line
with previous results (34, 35). In contrast, thymus and liver show
a comparably milder (8-fold) reduction in total NK cell frequencies
and numbers. As it was shown that thymic CD32 subset can in-
clude unconventional T cells with low surface CD3 levels (38), we
performed intracellular CD3 staining to confirm NK cell identity in
E4BP42/2 mice (Supplemental Fig. 1). Stainings for surface or
icCD3 yield similar frequencies (Supplemental Fig. 1A, 1B) and
absolute numbers (data not shown) of NK cells and therefore
confirm that we identify bona fide NK cells. In addition, T or
NKT cells do not coexpress the whole set of markers used in this
study to identify NK cells.
Lack of E4BP4 mainly affects the number of NK cells with
mature phenotype
Because thymus and liver contain NK subsets of immature phe-
notype, some of which may be of extramedullary origin, we de-
cided to further characterize the NK cells remaining in these
organs. A separate thymic NK cell lineage was previously iden-
tified as CD127+ NK cells. When we further divided the total
(CD42CD82CD32NK1.1+NKp46+CD122+) NK cell population
in the thymus on the basis of DX5 and CD127 expression, we
found that the NK population separates into a CD127+DX5int
subset and DX5highCD1272 NK cells (Fig. 2A). Whereas DX5
levels differ in the NK subsets, both are positive as compared with
CD3+ T cells in the same samples (Fig. 2A, red NK cell pop-
ulations compared with overlaid blue T cell population). These
two NK cell subsets are also found in spleen and liver (Fig. 2D,
2G), even though in the spleen the CD127+DX5int subset repre-
sents only a small fraction (4.4%) of NK cells. In contrast, both in
thymus and liver, this subset constitutes ∼40% of total NK cells in
wt mice. When we compared Ly49 expression on these two
subsets, we found Ly49D-positive NK cells only among the
DX5highCD1272 subset, confirming that these cells have a more
mature phenotype (Supplemental Fig. 2A–C). We then tested
which of these populations is more affected by E4BP4 deficiency.
Whereas the numbers of DX5highCD1272 NK cells were strongly
decreased in thymus, spleen, and liver, the CD127+DX5int subset
was not significantly reduced in thymus and spleen and was 6-fold
down in the liver (Fig. 2A, 2D, 2G). As DX5high NK cells rep-
resent ∼95% of all NK cells in the spleen (Fig. 2D), these results
explain why the greatest reduction in total numbers of NK cells is
seen in this organ (Fig. 1B).
Eomeshigh NK cells are most affected by E4BP4 deficiency
It was previously shown that the DX5low NK cells that are pre-
dominant in the liver express high levels of the surface marker
TRAIL, express lower levels of the transcription factor Eomes, and
constitute an immature NK subset (30, 39). We therefore assessed
Eomes levels on DX5highCD1272 and CD127+DX5low NK cell
subsets in thymus, spleen, and liver. In all organs, DX5highCD1272
NK cells have significantly higher Eomes levels than CD127+DX5low
NK cells (Fig. 2B, 2E, 2H). The residual DX5highCD1272 NK cells
in E4BP4-deficient mice show a significant reduction in Eomes
levels, whereas the low Eomes expression in the CD127+DX5int
subsets was not affected by the presence or absence of E4BP4
(Fig. 2B, 2E, 2H). In contrast to Eomes, expression of T-bet, another
transcription factor important for NK cell development, is high on
both NK subsets in all organs, and its expression is unaffected by
E4BP4 deficiency (Fig. 2C, Supplemental Fig. 2D, 2E). When we
assessed Ly49D expression, we found that absence of E4BP4 led to
a reduced frequency of Ly49D+ NK cells among the DX5high NK cell
subset (Supplemental Fig. 2A–C), which may be a reflection of the
lower Eomes levels in E4BP4-deficient DX5high NK cells.
TRAIL levels are low on all thymic NK cells (data not shown),
whereas both splenic and liver CD127+DX5int NK cells have
higher TRAIL levels than DX5highCD1272 cells (Fig. 2F, 2I) in
both wt and E4BP42/2 mice. Therefore, we conclude that the
CD127+ NK cells of thymic origin and the TRAIL+DX5low liver
FIGURE 1. NK frequencies and numbers are reduced in E4BP4-defi-
cient mice. The wt and E4BP42/2 thymi (A), spleens (B), and livers (C)
were analyzed for the presence of CD32NK1.1+NKp46+CD122+ NK cells.
Absolute numbers of total CD32NK1.1+NKp46+CD122 NK cells were
then calculated based on the gating strategy shown. Bars in the graph show
means 6 SD of replicates (n = 8–14); the fold reduction is indicated to the
right. Asterisks indicate statistically significant differences (unpaired t test:
**p , 0.01).
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NK cells described previously resemble each other in their low
Eomes levels and their immature phenotype as compared with
mature cNK cells of medullary origin. In conclusion, although the
development of DX5+ cNK cells is E4BP4 dependent, the CD127+
FIGURE 2. DX5high Eomeshigh NK cells are most affected by E4BP4 deficiency. Expression of CD127 and DX5 on NK cells (CD32NK1.1+NKp46+CD122+)
in wt and E4BP42/2 thymus (A), spleen (D), and liver (G). Absolute numbers of CD127+ and DX5high NK cells were determined, and fold reduction was
indicated for the liver (G). In (A), a plot from pregated CD3+ T cells (in blue) was overlaid onto the NK cells (in red) to distinguish DX5high and DX5low NK
populations from DX52 T cells. (B, E, and H) Levels of Eomes expression were determined by intracellular staining in the CD127+ and the DX5high NK subsets.
Mean fluorescence intensity values for Eomes (B, E, and H) and for TRAIL (H) are also shown. (C) Expression of the transcription factor T-bet in wt and E4BP42/2
thymic NK subsets. (F) Quantification of TRAIL expression on splenic NK subsets. (I) Eomes expression on TRAIL+ and DX5+ liver NK cell subsets. wt (black
line); E4BP42/2 (dashed line). Data are representative of at least four experiments. Error bars indicate SD. **p , 0.01, *p , 0.05. ns, not significant.
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and TRAIL+ subsets are affected by E4BP4 deficiency only re-
garding their cell number in the liver, with no effect of E4BP4 on
any of the other parameters considered in this study, including
Eomes and Ly49D expression.
NK cells can develop from thymic precursors in vitro in the
absence of E4BP4
CD127+ thymic NK cells were described to develop along a sep-
arate thymic pathway, and we show in this study that they are less
affected by E4BP4 deficiency. We therefore assessed directly
whether E4BP4-deficient CD4CD8 DN thymocytes still retain
a potential to differentiate into NK cells. We tested the ability of
lin2CD32CD1222CD42CD82 thymocytes to develop into NK
cells under established conditions in vitro (25) and found that the
absence of E4BP4 had little impact on the kinetics of NK cell
numbers and phenotype as assessed over 19 d of culture (Fig. 3A,
3C, 3D). In contrast, BM precursors from E4BP4-deficient mice
developed few, if any, NK cells under the same culture conditions
used above (25) or in conditions that were previously described
(34) and are optimized for BM precursors (Fig. 3B, 3C and data
not shown). We also tested the ability of DN-derived NK cells to
produce IFN-g in response to stimulation with IL-12 and IL-18
alone and in combination and showed that IFN-g production is
independent of the presence of E4BP4 (Fig. 3F).
We then measured the NK precursor frequency in different DN
subsets. We first established that, in both wt and E4BP4-deficient
cells, the potential for NK cell development is present in the
early DN1 (lin2CD32CD1222CD42CD82CD44+CD252) and DN2
(lin2CD32CD1222CD42CD82CD44+CD25+) subsets and absent in
T cell–committed DN3 (lin2CD32CD1222CD42CD82CD442
CD25+) and in CD4+CD8+ DP thymocytes (Fig. 3E and data not
shown). Further assessment of the NK precursor frequency within
DN1 and DN2 thymocytes by limiting dilution analysis indicated a
2-fold reduction between wt and E4BP4-deficient DN1 thymocytes
and no significant difference between the DN2 subsets (Fig. 3E). We
conclude that the NK potential of E4BP4-deficient DN thymocytes
is only marginally reduced.
NK cells develop in vivo independently of E4BP4 when T cell
development is blocked
Given that NK cells can develop in the absence of E4BP4 but in
massively reduced numbers and with an immature phenotype, we
attempted to generate in vivo conditions that might facilitate the
E4BP4-independent maturation of NK cells. Because DN thymo-
cytes have NK cell potential but only few NK cells are found in the
thymus, we hypothesized that Rag-1 deficiency, which blocks T and
B cell development in thymus and BM, may facilitate NK cell
development from thymic precursors. We therefore bred E4BP4-
deficient to Rag-1–deficient (Rag) mice to obtain DKO mice. In
DKO mice, NK cells (CD32NK1.1+NKp46+CD122+) are present in
the thymus at numbers that are comparable to those in the control
Rag mice (Fig. 4A, 4B). These cells are negative for intracellular
CD3, and therefore they do not represent unconventional T cells
with low CD3 levels (Supplemental Fig. 1C, 1D). However, on the
Rag background, the majority of NK cells are CD127+DX5high and
therefore differ from the thymic NK cells in wt mice (Fig. 4A).
We then compared NK cell numbers in spleen and liver of DKO
versus Rag mice. The 4-fold reduction in splenic NK cell numbers
FIGURE 3. Differentiation of NK cells from thymocytes is E4BP4 independent. Differentiation of NK cells from wt and E4BP4-deficient CD42CD82
DN thymocytes or BM precursors. (A) Lin2CD32CD42CD82 DN cells were sorted from wt, and E4BP4-deficient thymi or (B) lin2 precursors (CD11b2
CD11c2CD192Ter1192Ly6G2CD8a2CD3e2CD45R2NK1.12CD1222) were sorted from BM. After 14 d of culture on OP9 feeder cells, NK cells were
identified by FACS as CD32CD192NK1.1+NKp46+ cells (A, B). (C) Kinetic of NK cell development from DN or BM precursors. A single time course
experiment is shown in the left panels; data for days 6 and 10 pooled from three experiments are shown in the right panels. (D) Kinetics of phenotypic
maturation of DN-derived NK cells in vitro. (E) The frequency of NK precursors in total lin2CD32CD42CD82 DN thymocytes or DN subsets was
determined by limiting dilution analysis. Sorted cells were plated out at frequencies varying from 30 to 3000 cells/well, and frequencies of NK cell–positive
and –negative wells were used to calculate precursor frequencies in the cell subsets used. Data from four experiments were pooled for this analysis. (F)
Cytokine induced IFN-g production by CD32NKp46+NK1.1+ NK cells derived in vitro from wt or E4BP4-deficient DN thymocytes. After 14 d of culture,
NK cells were incubated for 16 h with the indicated cytokines, and IFN-g production was measured by intracellular cytokine staining. Error bars indicate
the SD of replicates (unpaired t test: *p , 0.05, **p , 0.01). ns, not significant.
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(Fig. 4E) is milder compared with the 34-fold difference in NK
cell numbers induced by E4BP4 deficiency in Rag-sufficient mice.
In the liver, we find no significant reduction in NK cell numbers
between DKO and Rag mice (Fig. 4H). There is also little change
in the ratio between CD127+ and DX5high NK cells (Fig. 4D, 4G).
When we assessed the impact of E4BP4 deficiency on Eomes
levels in DKO versus Rag mice, we find no change of Eomes
expression between NK cell subsets from DKO and Rag mice
(Fig. 4C, 4F, 4I). Like in Rag-sufficient mice, the CD127+DX5low
NK subset expresses less Eomes than DX5high NK cells in all
organs. Eomes levels tend to be generally lower in Rag-deficient
mice than in wt mice, independently of presence or absence of
E4BP4 (Fig. 4C, 4F, 4I). This difference is strongest in the thymus,
less pronounced in the spleen, and absent in the liver. We conclude
that, in a Rag-deficient background, lack of E4BP4 has less impact
on overall NK cell numbers, on the ratio between Eomeshigh and
Eomeslow NK cell subsets, or on Eomes expression levels.
Because frequencies of Ly49D+ NK cells were lower in
E4BP42/2 NK cells compared with wt cells, we assessed whether
this difference persists on a Rag-deficient background. All Ly49D+
NK cells present in the thymus are within the small CD1272DX5+
subset (Q3 in Supplemental Fig. 3A), whereas the bulk of CD127+
DX5high NK cells are Ly49D negative (Q2 in Supplemental Fig. 3A).
A lower proportion of the Q3 subset is Ly49D+ in DKO compared
with Rag control thymi (Supplemental Fig. 3B), which is similar to
the NK phenotype we find in E4BP42/2 thymi (Supplemental Fig.
2). In DKO thymi, Q3 NK cells also lack a proportion of pan-
Ly49high cells (Supplemental Fig. 3A). In contrast, all thymic NK
subsets express NKG2D, and a similar fraction expresses Ly49G2.
The reduced frequencies of Ly49D+ NK cells seen in the thymus are
FIGURE 4. Efficient development of
NK cells in E4BP4/Rag-1 DKO mice. (A)
Total live thymocytes from Rag-1–deficient
or DKO mice were analyzed by FACS for
the frequency of NK cells (CD32NK1.1+
NKp46+122+). (B) Absolute numbers of total
(CD32NK1.1+CD122+NKp46+) NK cells in
the thymus in a representative experiment of
five are shown. (C) FACS analysis of Eomes
levels in thymic CD127+DX5low [R1 in (A)]
and DX5high [R2 in (A)] cells from wt (filled
histogram), Rag-deficient (black line), and
DKO (dashed line) mice. Overlays of single
samples and quantification are shown. Total
live splenocytes (D, E) and liver lympho-
cytes (G, H) from wt, Rag-1–deficient, or
DKO mice were analyzed to determine the
frequency and absolute numbers of NK cells.
(F and I) FACS analysis and quantification
of Eomes levels in CD127+DX5low and
CD1272DX5high NK cells from wt (filled
histogram), Rag deficient (black line), and
DKO (dashed line). Error bars indicate the
SD of replicates (unpaired t test: *p, 0.05).
ns, not significant.
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also found in splenic and liver DX5high NK cell subsets, indicating
that E4BP4 deficiency impacts on the phenotype of these cells
(Supplemental Fig. 3C, 3D). Similar to the Rag-sufficient mice, all
NK cells in DKO and Rag mice were T-bet positive, and no dif-
ference in T-bet levels was found between NK subsets or between
E4BP4-sufficient and -deficient mice (data not shown).
NK cells in DKO mice are functionally normal and can develop
from thymic precursors
In functional assays, we found lower ability of DKO NK cells to
produce cytokines in response to single IL-12 or IL-18 stimulation. In
contrast, there was little difference in cytokine production or de-
granulation in response to a combined IL-12/IL-18 stimulus or to
NK1.1 or NKp46 cross-linking (Fig. 5A, 5B). Similarly, NK cell
recruitment into influenza-infected lungs was only slightly delayed in
DKO mice compared with Rag controls (Fig. 5C), and the recruited
cells showed similar level of activation, as measured by CD69 and
CD25 expression and IFN-g production (Fig. 5C and data not shown).
To test in vitro the possible origin of NK cells in DKO mice,
we tested the ability of DN1 thymic precursors and of lin2 BM
precursors to generate NK cells. In line with our findings in Rag-
sufficient mice, limiting dilution analysis indicated a similar
NK precursor frequency within DKO and Rag DN1 thymocytes
(Fig. 5D). In contrast, no NK cells developed from DKO BM
precursors (Fig. 5E). This result parallels the lower NK cell numbers
in the BM of DKO mice (Fig. 5F, 5G) and the dramatic loss of NK-
committed pre-NKP and NKP populations in DKO BM (Fig. 5H,
Supplemental Fig. 4). Hence, lack of E4BP4 does not affect thymic
NK development in a Rag-deficient background, whereas medullary
NK development is strongly reduced.
E4BP4-independent NK cell development is not restricted to
the thymus
To address in vivo whether E4BP4-independent NK cell devel-
opment takes place mainly in the thymus, we generated BM
chimeras by transferring DKO BM into irradiated wt controls or
FIGURE 5. Functionality and origin of NK cells in E4BP4/Rag-1 DKO mice. (A) Total live splenocytes from wt, Rag-1–deficient, or DKO mice were
exposed for 16 h to the indicated cytokines in the presence of brefeldin A, and IFN-g production by NK cells was measured by intracellular cytokine staining
(n = 3). Data shown are representative of three similar experiments. (B) Splenic wt and E4BP42/2NK cells were activated for 12 h with plate-bound anti-NK1.1
or anti-NKp46 Abs and evaluated for IFN-g production and degranulation (as determined by CD107a expression). Results are representative of three inde-
pendent experiments. For cytotoxicity, NK cells were mixed at the indicated ratio with YAC-1 target cells, and specific lysis was determined by net lactate
dehydrogenase release from target cells. (C) Lungs from uninfected (2), 3-d, or 5-d influenza-infected mice of indicated genotypes were prepared for enu-
meration of total and IFN-g+ NK cells by flow cytometry. (D) Determination of the frequency of NK precursors in total lin2CD32CD42CD82DN1 thymocytes
by limiting dilution analysis. Sorted cells were plated at frequencies varying from 30 to 3000 cells/well, and numbers of NK cell–positive and –negative wells
were used to calculate precursor frequencies. Data from three experiments were pooled for this analysis. (E) Lineage-depleted BM from the indicated mice was
cultured first for 5 d in SCF, Flt3L, and IL-7 and then for 7 d in IL-15 with OP9 stromal cells. Cells were then harvested and examined by flow cytometry, gating
by scatter and on OP9-GFP–negative cells. The frequency of NK1.1+CD192 NK cells among live GFP2 cells is shown. Result representative of three in-
dependent experiments. (F and G) Frequency of mature CD32NK1.1+ NK cells in the BM of DKO or Rag-1–deficient control mice (Rag). Individual plots (F)
and mean of three mice (G) are shown. (H) Flow cytometric quantification of frequencies of LMPP (lin2Sca1+ckit+Flt3+CD1272), CLP (lin2Sca1intckitintFlt3+
CD127+), pre-NKP (lin2CD27+2B4+CD127+Flt32CD1222), and refined NKP (lin2CD27+2B4+CD127+Flt32CD122+) in BM from the indicated mice. Means
of three mice are depicted. Error bars indicate SD of replicates (unpaired t test: *p , 0.05, **p , 0.01). ns, not significant.
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nude mice lacking thymic structures. We assessed reconstitution of
the NK cell population after 8 wk and after 8 mo and found at both
time points that presence or absence of a thymus did not impact on
the numbers of donor-type NK cells in spleen and liver (Fig. 6A).
Because thymic NK cells were shown to be IL-7 dependent (20),
and thymocyte development is dependent on IL-7, we crossed
DKO mice to IL-7–deficient mice to generate mice lacking E4BP4
and IL-7 on a Rag-1–negative background (triple deficient [TKO]).
In these mice, NK cell numbers and phenotype in spleen and liver
are identical to DKO controls (Fig. 6B, 6C and data not shown),
indicating that E4BP4-independent NK cell development is not
restricted by the lack of IL-7. Therefore, whereas the thymus may
contribute to NK cell generation in DKO mice, other extramedullary
origins such as the liver, or a slow and inefficient development in the
BM, could contribute to the NK cell population generated in nude
and TKO mice.
E4BP4-deficient NK cells develop inefficiently and have
reduced fitness
The fact that E4BP4 deficiency leads to a massive NK cell re-
duction in Rag-sufficient mice but has almost no impact on NK
cell development in Rag-deficient mice suggests that competition
between different cell subsets may play a role. To address this
question directly, mixed BM chimeras were generated by injecting
95% of DKO plus 5% of either wt or Rag BM cells into irradiated
Rag recipients. The rationale was to understand whether the pres-
ence of T and B cells would influence the efficiency of NK cell
generation. Fig. 7A shows that the presence of T and B cells in
fact reduces the numbers of NK cells developing from DKO BM,
confirming directly that competition with T and potentially B cells
strongly impacts on the numbers of E4BP4-deficient NK cells in
these mice.
We also noted in our mixed BM chimeras that, despite the 95:5
ratio of E4BP4-deficient (CD45.2+) to E4BP4-sufficient (CD45.1+)
BM input, the majority of NK cells in thymus, liver, and spleen
stemmed from the 5% E4BP4-sufficient BM input after 6 wk of
transfer (Fig. 7B). This finding can be due to two different causes:
first, it may be the result of reduced generation of E4BP4-deficient
NK cells due to slow extramedullary or inefficient medullary
FIGURE 6. E4BP4-independent NK cell development is not restricted
to the thymus. (A) The wt or nude recipient mice were lethally irradiated
and reconstituted with donor E4BP4/Rag-1 DKO BM cells (7 3 106) by
i.v. injection. Chimeric mice were maintained for 8 wk or 8 mo and an-
alyzed by FACS for the presence of NK cells (CD32NK1.1+NKp46+122+).
Absolute numbers of NK cells in the spleen and liver (A) were determined.
(B) FACS quantification of numbers of CD32NK1.1+NKp46+122+ NK
cells in thymus, spleen, and liver of E4BP4/Rag-1 (DKO) and E4BP4/IL-7/
Rag-1 (TKO) mice. (C) Flow cytometric plots show the characterization of
the CD32NK1.1+NKp46+122+ in the spleen of DKO and TKO animals.
Numbers indicate the percentage of cells in the gates depicted.
FIGURE 7. Delayed accumulation and reduced fitness of E4BP4-defi-
cient NK cells. (A) Mixed BM chimeras were generated by reconstituting
lethally irradiated Rag-22/2CD45.1+ mice with a mix of either 95% DKO
CD45.2+:5% wt CD45.1+ or with 95% DKO CD45.2+:5% Rag-22/2
CD45.1+ BM cells. The total number of CD45.2+ DKO NK cells in
thymus, spleen, and liver was determined 8 wk posttransplantation. (B)
Quantification of NK cells (CD32NK1.1+NKp46+122+) in 95% DKO
CD45.2+:5% Rag-22/2CD45.1+ BM chimeras. Bars indicate the number of
NK cells with Rag genotype as identified by CD45.1 expression or with
DKO genotype expressing CD45.2. (C) Flow cytometric quantification of
relative frequencies of DKO (CD45.2) and Rag (CD45.1) cells within
the LMPP (lin2Sca1+ckit+Flt3+CD1272), CLP (lin2Sca1intckitint Flt3+
CD127+), NKP (lin2CD27+2B4+CD127+Flt32) populations in the BM of
95% DKO CD45.2+:5% Rag-22/2CD45.1+ mixed BM chimeric mice. The
95% DKO: 5% Rag input is included to facilitate comparison. (D) Purified
wt CD45.1 T cells were injected into Rag or DKO mice, and CD45.2+ host
NK cells were quantified in the indicated organs. Fold decrease in NK cell
numbers in T cell–pulsed versus nonpulsed mice is shown. (E) Purified
hepatic or thymic lymphocytes from Rag-1 or E4BP4/Rag-1 DKO mice
were adoptively transferred into IL2rg2/2Rag-22/2 recipients and ana-
lyzed 21 d later. Total number of CD32NK1.1+NKp46+122+ NK cells was
determined in spleen and liver. Error bars indicate SD of replicates (un-
paired t test: *p , 0.05, **p , 0.01. ***p , 0.001). ns, not significant.
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development, whereas E4BP4-sufficient NK cells develop rapidly
mainly in the BM and populate peripheral tissues. Second, there
may be competition for survival or homeostatic proliferation in the
periphery between E4BP4-deficient and -sufficient NK cells, with
the E4BP4-sufficient NK cells prevailing. To distinguish directly
between these possibilities, we first analyzed the contribution of
the two genotypes to different BM precursor stages of the NK
cell lineage. Although early pluripotent BM precursors (lymphoid-
primed multipotent progenitors [LMPP]; Fig. 7C) are constituted
of .95% of DKO precursors, closely reflecting the BM input, the
contribution of DKO cells to NK-committed NKPs is dramatically
reduced (Fig. 7C). This indicates that indeed the E4BP4-deficient
BM input contributes little or nothing to intramedullary NK cell
generation.
To understand whether mature lymphocytes compete with NK
cells in the periphery, we transferred purified splenic CD45.1+ wt
T cells into Rag or DKO mice and measured the impact on resi-
dent NK cells. Fig. 7D shows that in BM, spleen, and liver, but not
in the thymus (data not shown), NK cell numbers are significantly
reduced upon transfer of mature T cells. In all organs, the re-
duction in NK cell numbers is greater in DKO mice than in Rag
mice, indicating that DKO NK cells are less able to compete with
T cells than Rag NK cells, explaining the more severe NK cell
phenotype in E4BP4 single-deficient mice than in DKO mice.
Taken together, our data indicate that, in the absence of E4BP4,
peripheral NK cells have reduced ability to survive and a reduced
fitness when competing with other lymphocytes or E4BP4-sufficient
NK cells.
E4BP4-deficient NK cells are more prone to apoptosis and
proliferate less well in response to IL-15
To further characterize the defects leading to reduced fitness of
E4BP4-deficient NK cells in vivo, we adoptively transferred thymic
or liver lymphocytes into IL-2rg2/2Rag-22/2 recipients. Three
weeks posttransfer, NK cell numbers recovered from the spleen or
liver were .20-fold lower when E4BP4-deficient DKO cells were
transferred as compared with Rag control cells (Fig. 7E), indi-
cating that E4BP4 deficiency may impact on the cell’s ability to
proliferate even in the absence of competition.
To assess this, we cultured NK cells for 12 h in full medium and
assessed survival and apoptosis of cells. Both splenic and hepatic
NK cells from Rag mice survived better in vitro than DKONK cells
(Fig. 8A, 8B). Similar differences were found after 4 and 6 h in
culture (data not shown), explaining the low NK cell recovery we
had noticed in functional tests in vitro (Fig. 5A, 5B). When NK
cells were incubated with IL-15 for 3 d, we found reduced cell
division of DKO NK cells (Fig. 8C), resulting in lower cell re-
covery (Fig. 8D). The reduced response to IL-15 is not caused by
lower IL-15R levels, as no differences were found between Rag
and DKO NK cells by flow cytometry for the IL-15R b-chain
(CD122; Fig. 4 and data not shown) or the IL-15R a-chain (Fig. 8D)
or by quantitative PCR for these chains on sorted splenic NK cells
(data not shown). Together, our data indicate that a higher rate of
apoptosis and a reduced ability to proliferate in response to the
central maintenance factor IL-15 most likely contribute to reduced
NK cell fitness in E4BP4-deficient mice.
Higher NK cell turnover in E4BP4-deficient mice
Given the reduced ability of E4BP4-deficient NK cells in DKO
mice to develop in the BM, the lower fitness, higher apoptosis rates,
and lower responsiveness to IL-15, it could be argued that NK cell
numbers are surprisingly similar in DKO versus Rag mice. To
understand whether compensatory mechanisms are in action, we
pulsed Rag and DKO mice with EdU for 12 h and assessed the
degree of EdU incorporation, an indication of DNA synthesis and
therefore proliferation within the pulse period. Fig. 9 shows that in
all organs except the thymus, a higher fraction of DKO than Rag
NK cells has incorporated EdU, indicating a higher degree of NK
cell proliferation in DKO mice. Similar differences were found
when EdU was given daily for 3 or 6 d (data not shown). This
proliferation most likely serves to compensate for the reduction in
NK cell development from precursors and for the lower ability of
DKO NK cells to survive and compete for survival niches in the
periphery.
Discussion
During hematopoiesis, hematopoietic stem cells give rise to pro-
gressively more restricted precursor cells that include both
lymphoid-restricted CLP and precursors with myeloid-restricted
potential (CMP). In the mouse, restriction to the innate lym-
phoid lineage (including the NK lineage) is mediated by the
transcription factor Id2 (12, 28), whereas several other transcrip-
tion factors are required for further development along the NK
lineage (40). Among these, the transcriptional activator/repressor
E4BP4 is absolutely necessary for the development of cNK cells
in the BM (34, 35). In this study, we reassess this requirement and
define in vitro and in vivo conditions of E4BP4-independent NK
cell maturation.
FIGURE 8. Increased apoptosis and reduced responsiveness to IL-15 of
E4BP4-deficient NK cells. (A) Flow cytometric analysis of splenic or liver
lymphocytes cultured for 12 h in complete medium. Cells were stained
for NK cell markers, the DNA dye ToPro and Annexin V. Dot plots
show pregated CD32NK1.1+NKp46+DX5+CD122+ NK cells that are live
(ToPro2Annexin V2 DN) or apoptotic and dead (ToPro+Annexin V+ DP).
Cells were quantified in (B). (C) Splenocytes were CFSE loaded and in-
cubated for 3 d in complete medium in the presence or absence of IL-15.
CFSElo NK cells that have undergone at least one division are shown. (D)
NK cell recovery at the end of the IL-15 culture period. (E) Splenic NK
cells were stained ex vivo for IL-15Ra expression. Results are represen-
tative of three experiments. Error bars indicate SD of replicates (unpaired
t test: *p , 0.05, **p , 0.01). ns, not significant.
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In E4BP4-deficient mice, the numbers of cNK cells in the
thymus, spleen, and liver are strongly reduced, whereas numbers of
NK cells with an immature phenotype and low Eomes expression
levels are less affected. This is particularly evident in both the
thymus and liver, where a high proportion of NK cells show this
particular immature phenotype. We therefore claim that E4BP4 is
not strictly required for the development of NK cells resident in
peripheral organs.
To support this hypothesis, we demonstrate that E4BP4-deficient
DN1 and DN2 thymic precursors are able to develop into NK cells
in vitro with similar kinetics, precursor frequencies, phenotype,
and function as wt controls. Furthermore, in Rag-1–deficient mice
lacking T and B cells, NK precursor frequency and NK cell
numbers in the thymus and liver are unaffected by absence of
E4BP4 expression, and the phenotype and function of NK cells
are similar between these Rag-12/2E4BP42/2 (DKO) mice and
Rag-12/2 (Rag) controls. These data allow us to conclude that in
a T/B cell–depleted environment, NK cells have the necessary
conditions to develop and expand independently of E4BP4 ex-
pression. The apparent competition for survival factors between
T/B cells and NK cells is supported further by the observation that
mixed BM chimeras have reduced numbers of E4BP4-deficient
NK cells when T and B cells are present, or in the presence of
competing E4BP4-sufficient NK cells. We could narrow the
competing cell type further down to T cells, as transfer of mature
splenic T cells leads to a reduction of NK cells in Rag and DKO
mice. In all organs, NK cell reduction due to T cell competition is
greater in DKO than in Rag mice, confirming the reduced fitness
of E4BP4-deficient NK cells and explaining why E4BP4-deficient
mice that are Rag sufficient show a much stronger NK cell de-
pletion.
Despite the fact that E4BP4 expression appears to be nones-
sential for extramedullary NK cell development, E4BP4-deficient
NK cells display reduced fitness when compared with E4BP4-
sufficient counterparts, as shown by experiments in which adop-
tive transfer of peripheral NK cells reveals reduced ability of
E4BP4-deficient cells to survive and expand in the periphery.
Moreover, in in vitro experiments, E4BP4-deficient cells are more
prone to apoptosis and less able to proliferate in response to IL-15.
Overall, these data support the concept that NK cells with immature
phenotype develop independently of E4BP4 peripheral organs and
that NK cell generation from thymic precursors does not require
E4BP4. However, E4BP4-deficient NK cells found in the periphery
are less fit than wt NK cells and disappear rapidly in the absence of
constant replenishment.
In Rag-sufficient mice, the common denominators of E4BP4-
dependent NK cells are their mature phenotype, their high Eomes
levels, and potentially their intramedullary development. In contrast,
NK cells that do not require E4BP4 share amore immature phenotype,
lower Eomes levels, and potential extramedullary origin. In general,
the phenotype of tissue-resident NK cells appears more immature as
compared with that of BM-derived NK cells. For instance, the liver-
resident TRAIL+DX52 subset of NK cells has a less diverse Ly49
repertoire than cNK cells (30, 39, 41). Similarly, low fractions of
CD127+ thymic NK cells express Ly49D and other Ly49 markers,
and CD11b levels are lower on thymic compared with splenic
NK cells (20). In the absence of E4BP4, numbers of mature
DX5high NK cells are reduced in all organs assessed, and the
remaining cells show a changed Ly49 repertoire, with fewer cells
expressing Ly49D and other Ly49 family members, indicating
that the remaining DX5high NK cell populations have a more
immature phenotype.
This clear difference in E4BP4 requirements between mature
and immature NK cell subsets suggests that either there are distinct,
E4BP4-dependent, and independent developmental pathways, or
that the more immature NK cells found in E4BP42/2 mice are
blocked at some stage of their maturation. We favor the hypothesis
of distinct pathways based on our findings that thymic, but not
BM, precursors allow E4BP4-independent NK cell development
in vitro. In addition, the normal number of NK cells in thymus and
liver of Rag-1/E4BP4 DKO mice are in contrast to strongly re-
duced NK cell frequencies and NK precursor numbers in the BM
of these mice, suggesting that the majority or even all NK cells we
find in DKO mice are of extramedullary origin. In vivo, we do not
find evidence of the thymus as the sole organ required for E4BP4-
independent NK cell development, but other sites such as the liver
may contribute as well. Alternatively, intramedullary development
may be strongly reduced but not completely blocked in E4BP4-
deficient mice, thus allowing accumulation of NK cells in specific
sites over time.
NK cell numbers are similar in thymus and liver of DKO mice
and Rag controls and reduced only by a factor of 4 in the spleen. In
contrast, NK cell frequencies and numbers are more strongly af-
fected by E4BP4 deficiency in Rag-sufficient mice. Adoptive
transfer and BM chimera experiments show that the more severe
phenotype of E4BP4 single-knockout mice is at least partly due to
a reduced fitness that becomes evident in the presence of competing
cells, but less so in their absence in DKOmice. The development of
E4BP4-deficient NK cells in DKO mice has allowed us further
examination of the NK cell deficiencies in the absence of this
transcription factor. We confirm a severe block in intramedullary
NK cell development and find in addition that peripheral main-
tenance is characterized by an overall higher turnover of the NK
cell population in DKO compared with Rag mice that compensates
for a reduced responsiveness to the NK survival factor IL-15 and
a higher frequency of apoptosis of peripheral NK cells. In contrast,
NK cell functions such as degranulation and cytokine production
in response to inflammatory cytokines or receptor cross-linking
FIGURE 9. Increased turnover of NK cells in DKO mice. (A) Ex vivo
flow cytometric analysis of EdU incorporation by NK cells after a 12-h
EdU pulse in vivo. Pregated CD32NK1.1+NKp46+122+ NK cells were
identified as EdU positive, as shown in (A) and quantified (B). Error bars
indicate SD of replicates (unpaired t test: *p , 0.05). ns, not significant.
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in vitro and to virus infection in vivo are only mildly affected when
measured by single-cell assays. Because DKO NK cell survival
in vitro is compromised, we think that the reduction in cytotoxicity
we observe in in vitro assays is partly, if not mainly, due to NK cell
loss during this bulk assay. Together, our data point to a major
role of E4BP4 in NK cell development and for maintenance in
a competitive peripheral environment, whereas mature NK cell
functions are largely independent of E4BP4.
A recent report of E4BP4 deletion induced postintramedullary
development finds that the mature NK cell population is maintained
in the absence of E4BP4, results that are largely in agreement with
our findings in Rag-negative mice (42). This study did, however,
not analyze NK cell turnover or IL-15 responsiveness; therefore,
the NK population followed in that study may have homeostatic
dynamics that are different from wt NK populations, as was the
case when we compared NK cell turnover in Rag and DKO mice.
At difference with our results, Firth et al. (42) find no loss of
competitive fitness upon E4BP4 deletion in peripheral NK cells,
which may suggest that the absence of E4BP4 during development
(in our system) prevents induction of factors crucial for NK cell
homeostasis in a competitive environment.
Previous studies have shown that, in the absence of E4BP4,
transcription factors crucial for intramedullary NK cell development
such as Id2 and Gata3 are not upregulated, leading to a develop-
mental block (34, 35). We confirm this block and find no indication
in vitro that BM cells develop into NK cells independently of
E4BP4. In contrast, E4BP4-deficient NK cells can develop from
DN thymocytes in vitro, and preliminary analysis showed no sig-
nificant differences between wt and E4BP4-deficient NK cells in
levels of Id2 or Gata3 (data not shown). This suggests that there are
E4BP4-independent pathways to induce these transcription factors,
ultimately leading to the establishment of an almost complete NK
expression program. It was previously shown that Gata3 is im-
portant for the development of thymic NK cells (20). We suggest
that NK cell development from DN thymocytes involves T cell–
related transcription factors including Gata3 (43) and thereby
bypasses the necessity of E4BP4 for induction of more downstream
transcription factors. In contrast, BM precursors appear to be more
dependent on E4BP4 and less able to use alternative pathways,
circumventing the requirement of E4BP4 for development into the
NK cell lineage.
Downstream transcription factors such as T-bet and Eomes have
been shown to be required for NK cell identity (30), and it is
possible that E4BP4 plays a role in their induction. Both cNK cells
and a newly described intraepithelial innate lymphocyte cell 1
subset express high Eomes levels and are reduced in the absence
of E4BP4 (34, 35, 44). This and the independent, copublished
study by Seillet et al. (45) demonstrate that the naturally Eomeslow
thymic CD127+DX5low and liver DX52TRAIL+ NK cell pop-
ulations are less affected by E4BP4 deficiency than Eomeshigh
DX5+CD1272TRAIL2 NK cells. The residual NK cells with
mature phenotype present in E4BP4-deficient mice show lower
Eomes levels than the corresponding subset in wt mice. In con-
trast, T-bet levels are similar in all NK cell subsets and in E4BP4-
deficient and control mice. These data are consistent with a role of
E4BP4 in the upregulation specifically of Eomes but not of T-bet
in NK cells.
We also show that NK cells in Rag-1–deficient thymi have lower
Eomes levels compared with wt cells. A similar trend is found in
other organs assessed in this study. The more immature, Eomeslow
NK subsets of CD127+ and TRAIL+ NK cells in thymus and liver
are also increased in Rag-1–deficient mice. In addition, Eomes
levels in NK cells do not differ significantly between DKO and
Rag controls, which may help explain the lower impact of E4BP4
deficiency on NK cell development in these genetic backgrounds.
If extramedullary NK cell development requires high Eomes
levels in a Rag-1–sufficient context, then lack of E4BP4 and
subsequent lack of Eomes upregulation will lead to a reduction
in this cell population. In contrast, if low amounts of Eomes
are sufficient for NK cell development and more NK cells are
Eomeslow in the absence of Rag-1, then presence or absence of
E4BP4 will be of little consequence, as seen in the DKO mice.
The Rag-dependent developmental block may facilitate NK cell
development either by allowing precursor commitment to the NK
cell lineage or by lack of competition for thymic niches or soluble
factors such as IL-7 that were shown to be crucial for thymic NK
cell development (20). However, the efficient NK cell develop-
ment in TKO mice shows that IL-7 is not crucial for E4BP4-
independent NK cell development.
In conclusion, we demonstrate in vivo and in vitro that NK cells can
develop independently of E4BP4, leading to populations with im-
mature phenotype. We propose that separate, extramedullary devel-
opmental pathways, for instance in the thymus or the liver, may
contribute to the generation of these NK cells. Our data indicate that
transcription factor requirements may vary for different pathways of
NK cell development. In the absence of competing lymphocyte
populations, E4BP4-independent NK cell development and survival
are facilitated, but resulting NK cells turn over faster as a consequence
of higher apoptosis rates and lower responsiveness to IL-15. Taken
together, our data suggest that E4BP4 affects not only NK cell de-
velopment and phenotype but also their fitness and survival.
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